Subacute StrokeROOMMATENCT06728020
AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care. (ROOMMATE)
A study testing Active Comparator: Conventional rehabilitation (Group A), ROOMMATE 1st and ROOMMATE 2nd in people with Subacute Stroke and Stroke; Subacute, run by Francesca Cecchi at 1 site in Italy.
Trial summary
The aim of this clinical trial is to assess whether the ROOMMATE system can effectively support the rehabilitation of adults recovering from subacute strokes. The study will be conducted at the neuromotor rehabilitation inpatient clinics of IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and the rehabilitation… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Subacute Stroke, Stroke; Subacute
- What is being tested?
- Active Comparator: Conventional rehabilitation (Group A), ROOMMATE 1st and ROOMMATE 2nd
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteItaly
- Study dates
- Apr 2025to May 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- outcome of ischemic or hemorrhagic stroke in subacute phase (< 3 months after the event)
- willingness to participate in the project, with informed consent signed by the subject or, when necessary, by the support administrator.
Who cannot join
- severe visual and/or auditory impairments that cannot be corrected
- severe cognitive and/or speech impairments that interfere with the ability to use the HKK system and the SensoMode accessory independently and/or in the
- absence of a caregiver who can assist the patient in using the system;
- skin lesions that prevent wearing the inertial sensors;
- presence of signs of clinical instability, defined by a score greater than zero on the Clinical Instability Scale (SIC).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site
IRCCS Fondazione Don Carlo Gnocchi Onlus
Florence, Florence
Francesca Cecchi, Associate Professor, +39 3388627184, fcecchi@dongnocchi.it
Stefano Doronzio, PT, Phds, +39 3924685537, sdoronzio@dongnocchi.it
About this study
Official title: ROOMMATE - AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care.
The aim of this clinical trial is to assess whether the ROOMMATE system can effectively support the rehabilitation of adults recovering from subacute strokes. The study will be conducted at the neuromotor rehabilitation inpatient clinics of IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and the rehabilitation inpatient unit of Elias University Emergency Hospital in Bucharest, Romania.
Primary Objectives:
Read more
-To assess the effects on functional recovery in subacute stroke survivors of a technological rehabilitation station placed at patients' bedsides, combined with dedicated coaching provided to all users (patients, informal caregivers, and formal caregivers).
Secondary Objectives:
- Evaluation of the effects of the experimental treatment on patient satisfaction, upper limb motor skills, manual dexterity, global cognitive functioning, anxiety, and depression.
- Assessment of user experience, acceptance, and usability of the technology by patients and caregivers.
- Evaluation of social impact using the Social Return on Investment (SROI) ratio of the experimental treatment.
Participants randomized into one of the experimental groups, in addition to receiving conventional care, will use the ROOMMATE system during their hospitalization. The system will be made available to patients and will be free for them to use at their discretion.
The station will include:
Multimedia monitors (Khymeia home kit): These will deliver cognitive and motor serious games, educational and rehabilitative content, as well as infotainment specifically developed by the clinical partners of the project.
An inertial sensor kit: This integrates with the monitors to guide users through virtual reality environments.
Read the detailed description
Study Procedures
The study involves three successive phases:
Phase 1 During the first phase, after obtaining Ethics Committee approval, Living Labs will be planned. In these sessions, end users will test the proposed solutions and provide feedback on acceptability and usability. This phase is critical for defining user and system requirements. Additionally, health professionals will be trained as system coaches to support patients and their families in the subsequent phases.
The coaches will be selected from health professionals (physical therapists, occupational therapists, speech therapists, psychologists, nurses) with at least three professionals per center. They will complete a one-week course in digital literacy (e-literacy), covering:
- Technical and operational skills for managing and using digital technologies.
- Information and navigation skills.
- Specific training on the use of the Khymeia Home Kit.
- Training on using the inertial sensors developed by UNIFI. The training will conclude with a written and practical exam.
Subsequently, a multicenter multiple cohort RCT (cmRCT) will be conducted, consisting of two trials:
- A first RCT (Phase 2 of the study).
- A second pilot RCT (Phase 3 of the study). The study will be carried out in an inpatient setting for individuals with subacute stroke outcomes at the two clinical centers: IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and Elias University Emergency Hospital in Bucharest, Romania.
The cmRCT design was chosen to address some limitations of traditional RCTs, such as issues with recruitment, ethics, patient preferences, and treatment comparison. Moreover, the cmRCT allows the simultaneous evaluation of different interventions.
In ROOMMATE, eligible patients who consent to baseline (T0) and final (T1, three weeks later) assessments may also be offered an additional intervention, forming the ROOMMATE Study Cohort. A subset of these patients will be randomized to receive an offer to participate in the ROOMMATE Interventions (B or B1), while those not randomized will form the control group (A, receiving usual care). This design will allow two successive RCTs to be conducted.
Phase 2
The first RCT will compare usual care (A) with a preliminary version of the ROOMMATE solution (B), which includes:
- Usual care.
- The Khymeia Home Kit monitor.
- Educational and rehabilitative content developed by clinical partners.
- Coaching for technology use. The sample size for this RCT is 140 patients, randomly assigned to Group A or B, with competitive enrollment across the two clinical centers.
The Khymeia Home Kit, supplemented with educational content, can be used by patients alone or with a caregiver. The educational materials will include:
- General information about stroke pathogenesis and prognosis.
- Strategies and advice for managing the condition.
- Health-related content, such as details on daily hospitalization routines, the roles of various care professionals, and discharge management (including bureaucratic aspects).
- Information on local support networks. Additional cognitive and motor rehabilitation content will be developed by a multidisciplinary team and customized by department therapists to match each patient's needs and recovery potential.
The coach will be available in person five days a week to support all end users in using the ROOMMATE technology.
Phase 3
Following the completion of the first RCT, a second pilot RCT with 60 patients will test usual care (A) against a mature version of the ROOMMATE solution (B1). This includes:
- Usual care.
- Motor and cognitive treatment supported by inertial sensor assessment for personalized interventions.
- Integration of clinical assessments with IMU-derived reports.
- Educational and rehabilitative content developed by clinical partners.
- Coaching for technology use. In Group B1, the Khymeia Home Kit (with educational and rehabilitation content) will be enhanced with inertial sensors developed by UNIFI. These sensors will measure hand motility and provide tailored rehabilitation interventions.
The ROOMMATE intervention will last three weeks per patient. During this period:
- Group B patients will receive training in using the technology from the coach.
- Patients and their families will have self-directed or supervised access to HKK features, including educational, rehabilitative, and infotainment content.
- Therapists will recommend the most appropriate content based on the patient's needs.
- In Group B1, the physician will use inertial sensor data to quantify motor deficits and tailor the treatment accordingly.
Assessments (T0 and T1)
At baseline (T0) and post-treatment (T1), the following will be assessed:
- Demographics: Sex, age, education.
- Clinical data: Type of stroke, time since stroke, lesion laterality.
- Primary and secondary outcomes: Disability in ADLs (modified Barthel Index, mBI). Manual dexterity. Upper limb motor skills. Neuropsychological and global cognitive functioning. Anxiety and depression. Quality of life.
At post-treatment (T1), also the following will be assessed:
- Primary and secondary outcomes: Usability, feasibility, and social impact measures. User experience and education evaluation. Wearability of sensors. Social impact and patient satisfaction.
- Conditions
- Subacute Stroke, Stroke; Subacute
- Being tested
- Active Comparator: Conventional rehabilitation (Group A), ROOMMATE 1st, ROOMMATE 2nd
- Keywords
- subacute stroke, Neurorehabilitation, Assistive/rehabilitation robotics, Digital health, Continuum of care, People-centered care, Accessible care, Innovation adoption, cmRCT, Enriched environment
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Active Comparator: Conventional rehabilitation (Group A)Other
The conventional group will undergo standard rehabilitation treatment according to the rehabilitation plan developed by the rehabilitation team. This group will undergo 3 hours of rehabilitation per day and will carry out face-to-face rehabilitation following an impairment-based approach aimed at the treatment of motor-cognitive functions.
ROOMMATE 1stDevice
In addition to Group A, this group will have the bedside multimedia monitor apparatus to access informative, rehabilitation, and entertainment content. Additionally, this group will have a digital and innovation coach to receive support in using the technology.
ROOMMATE 2ndDevice
Once the first RCT of the cmRCT is completed, a pilot RCT will be initiated, randomizing 60 cases between Group A and this group. In addition to conventional treatment, this group will have a version of the ROOMMATE system integrated with inertial sensors worn on the hands and fingers to guide the serious games on the platform.
| Study group | Role | What they receive |
|---|---|---|
| Conventional rehabilitation (Group A) | Active comparator | The first 140 patients who meet the inclusion criteria will be randomized between this group and group B. This group will undergo conventional therapy. Receives: Other: Active Comparator: Conventional rehabilitation (Group A) |
| ROOMMATE 1st (Group B) | Experimental | The 70 patients randomized to this group will undergo conventional treatment and, in addition, will have the first version of the ROOMMATE system. Receives: Device: ROOMMATE 1st |
| ROOMMATE 2nd (Goup B2) | Experimental | Group B2 will undergo conventional treatment and will have an extended version of the bedside multimedia monitor apparatus, integrated with an inertial sensor to enable the serious games on the experimental platform. Receives: Device: ROOMMATE 2nd |
What is being measured
The primary outcome is the main question the study is designed to answer.
modified Barthel index (mBI)
Assessment of disability in ADLs, scoring 0-100
Measured: baseline, 3 week
Secondary outcomes (12)
Nine Hole Peg Test
Manual Dexterity, evaluated in seconds
Measured: baseline, 3 week
Fugl Meyer Assessment (FMA)
Upper limb motor skills, scoring 0 - 126
Measured: baseline, 3 week
Functional Ambulation Category (FAC)
functional ambulation assessment, scoring 0-5
Measured: baseline, 3 week
Montreal Cognitive Assessment (MOCA)
Cognitive impairment assessment, scoring 0 - 30
Measured: baseline, 3 week
Hearts Test
3-minute visual attention barrage test, scores 0-50
Measured: baseline, 3 week
Short Form 12 item
generic assessment of quality of life, scoring 0-47
Measured: baseline, 3 week
Training-Evaluation-Inventory (TEI)
evaluation of the course and its contents, a 45 item scale scoring with a 5 point likert scale
Measured: 3 week
Short Version of the User Experience Questionnaire (UEQ-S)
user expirience assessment, 8 item scale scoring with a 7 point likert scale
Measured: 3 week
Final Measurement Scales for Perceived Usefulness and Perceived Ease of Use
Acceptance Assessment of the ROOMATE sistem, a 12 item scale scoring with a 7 point likert scale
Measured: 3 week
HUBBI - eHealth UsaBility Benchmarking Instrument
Usability Assessment of the ROOMATE sistem, a 18 item scale scoring with a 5 point likert scale
Measured: 3 week
we wearability test
Sensors Wearability Assessment, likert scale, scores 1-5
Measured: 3 week
Motricity Index
Upper limb and lower limb motor skills, scoring 0 - 100
Measured: baseline, 3 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Dec 2024
- Study startApr 2025 (estimated)
- Primary completionMay 2026 (estimated)
- Study completionMay 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Subacute StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Three phases: in the first, focus groups and living labs are conducted to co-create the solution with patients; in the second, as the first action of the cmRCT, an RCT is conducted to verify the effectiveness of the initial ROOMMATE system; in the third, a pilot is conducted to preliminarily test the advanced version of the ROOMMATE system.
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Francesca Cecchi
- Sponsor type
- University, hospital or other
- Collaborators
- MEDEA, Italy, Carol Davila University of Medicine and Pharmacy, Roessingh Research and Development, University of Florence
- Responsible party
- Sponsor-investigator, Francesca Cecchi, Fondazione Don Carlo Gnocchi ETS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06728020
- Sponsor's protocol ID
- cmRCT ROOMMATE
- Other IDs
- Grant Agreement Nº: 101095654.
- Acronym
- ROOMMATE
- Status last verified
- Mar 2025
- First submitted
- 27 Nov 2024
- Last updated
- 21 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: After publishing the results in international congresses and conferences and in impacted journals, the project partners, according to the stipulated data management plan will disseminate the results following the principle of "as open as possible, as closed as needed". Resuls will be shared on a Zenodo-like repository.
Publications
Doronzio S, Jansen-Kosterink S, Tesi M, Castagnoli C, Pedrini C, Ciapetti T, De Marco M, Piazzini M, Giacani J, Ciobanu I, Berteanu M, Fiorini L, Rovini E, Cavallo F, Agnoloni F, Baccini M, Cecchi F. Development of a cohort multiple randomized clinical trial to test an integrated system of sensors and multimedia monitors technology, for stroke rehabilitation: the ROOMMATE study protocol. Front Neurol. 2025 Oct 14;16:1568728. doi: 10.3389/fneur.2025.1568728. eCollection 2025.
PubMed 41164394
Study at a glance
From the registry record, last updated by the sponsor on 21 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- ROOMMATE - AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care.
- ClinicalTrials.gov ID
- NCT06728020
- Acronym / sponsor ID
- ROOMMATE / cmRCT ROOMMATE
- Conditions
- Subacute Stroke, Stroke; Subacute
- Keywords
- subacute stroke, Neurorehabilitation, Assistive/rehabilitation robotics, Digital health, Continuum of care, People-centered care, Accessible care, Innovation adoption
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Francesca CecchiUniversity, hospital or other
- Collaborators
- MEDEA, Italy, Carol Davila University of Medicine and Pharmacy, Roessingh Research and Development, University of Florence
- Study start
- Apr 2025 (estimated)
- Primary completion
- May 2026 (estimated)
- Study completion
- May 2026 (estimated)
- First posted
- 11 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this clinical trial is to assess whether the ROOMMATE system can effectively support the rehabilitation of adults recovering from subacute strokes. The study will be conducted at the neuromotor rehabilitation inpatient clinics of IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and the rehabilitation inpatient unit of Elias University Emergency Hospital in Bucharest, Romania.
Primary Objectives:
-To assess the effects on functional recovery in subacute stroke survivors of a technological rehabilitation station placed at patients' bedsides, combined with dedicated coaching provided to all users (patients, informal caregivers, and formal caregivers).
Secondary Objectives:
- Evaluation of the effects of the experimental treatment on patient satisfaction, upper limb motor skills, manual dexterity, global cognitive functioning, anxiety, and depression.
- Assessment of user experience, acceptance, and usability of the technology by patients and caregivers.
- Evaluation of social impact using the Social Return on Investment (SROI) ratio of the experimental treatment.
Participants randomized into one of the experimental groups, in addition to receiving conventional care, will use the ROOMMATE system during their hospitalization. The system will be made available to patients and will be free for them to use at their discretion.
The station will include:
Multimedia monitors (Khymeia home kit): These will deliver cognitive and motor serious games, educational and rehabilitative content, as well as infotainment specifically developed by the clinical partners of the project.
An inertial sensor kit: This integrates with the monitors to guide users through virtual reality environments.
Detailed description
Study Procedures
The study involves three successive phases:
Phase 1 During the first phase, after obtaining Ethics Committee approval, Living Labs will be planned. In these sessions, end users will test the proposed solutions and provide feedback on acceptability and usability. This phase is critical for defining user and system requirements. Additionally, health professionals will be trained as system coaches to support patients and their families in the subsequent phases.
The coaches will be selected from health professionals (physical therapists, occupational therapists, speech therapists, psychologists, nurses) with at least three professionals per center. They will complete a one-week course in digital literacy (e-literacy), covering:
- Technical and operational skills for managing and using digital technologies.
- Information and navigation skills.
- Specific training on the use of the Khymeia Home Kit.
- Training on using the inertial sensors developed by UNIFI. The training will conclude with a written and practical exam.
Subsequently, a multicenter multiple cohort RCT (cmRCT) will be conducted, consisting of two trials:
- A first RCT (Phase 2 of the study).
- A second pilot RCT (Phase 3 of the study). The study will be carried out in an inpatient setting for individuals with subacute stroke outcomes at the two clinical centers: IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and Elias University Emergency Hospital in Bucharest, Romania.
The cmRCT design was chosen to address some limitations of traditional RCTs, such as issues with recruitment, ethics, patient preferences, and treatment comparison. Moreover, the cmRCT allows the simultaneous evaluation of different interventions.
In ROOMMATE, eligible patients who consent to baseline (T0) and final (T1, three weeks later) assessments may also be offered an additional intervention, forming the ROOMMATE Study Cohort. A subset of these patients will be randomized to receive an offer to participate in the ROOMMATE Interventions (B or B1), while those not randomized will form the control group (A, receiving usual care). This design will allow two successive RCTs to be conducted.
Phase 2
The first RCT will compare usual care (A) with a preliminary version of the ROOMMATE solution (B), which includes:
- Usual care.
- The Khymeia Home Kit monitor.
- Educational and rehabilitative content developed by clinical partners.
- Coaching for technology use. The sample size for this RCT is 140 patients, randomly assigned to Group A or B, with competitive enrollment across the two clinical centers.
The Khymeia Home Kit, supplemented with educational content, can be used by patients alone or with a caregiver. The educational materials will include:
- General information about stroke pathogenesis and prognosis.
- Strategies and advice for managing the condition.
- Health-related content, such as details on daily hospitalization routines, the roles of various care professionals, and discharge management (including bureaucratic aspects).
- Information on local support networks. Additional cognitive and motor rehabilitation content will be developed by a multidisciplinary team and customized by department therapists to match each patient's needs and recovery potential.
The coach will be available in person five days a week to support all end users in using the ROOMMATE technology.
Phase 3
Following the completion of the first RCT, a second pilot RCT with 60 patients will test usual care (A) against a mature version of the ROOMMATE solution (B1). This includes:
- Usual care.
- Motor and cognitive treatment supported by inertial sensor assessment for personalized interventions.
- Integration of clinical assessments with IMU-derived reports.
- Educational and rehabilitative content developed by clinical partners.
- Coaching for technology use. In Group B1, the Khymeia Home Kit (with educational and rehabilitation content) will be enhanced with inertial sensors developed by UNIFI. These sensors will measure hand motility and provide tailored rehabilitation interventions.
The ROOMMATE intervention will last three weeks per patient. During this period:
- Group B patients will receive training in using the technology from the coach.
- Patients and their families will have self-directed or supervised access to HKK features, including educational, rehabilitative, and infotainment content.
- Therapists will recommend the most appropriate content based on the patient's needs.
- In Group B1, the physician will use inertial sensor data to quantify motor deficits and tailor the treatment accordingly.
Assessments (T0 and T1)
At baseline (T0) and post-treatment (T1), the following will be assessed:
- Demographics: Sex, age, education.
- Clinical data: Type of stroke, time since stroke, lesion laterality.
- Primary and secondary outcomes: Disability in ADLs (modified Barthel Index, mBI). Manual dexterity. Upper limb motor skills. Neuropsychological and global cognitive functioning. Anxiety and depression. Quality of life.
At post-treatment (T1), also the following will be assessed:
- Primary and secondary outcomes: Usability, feasibility, and social impact measures. User experience and education evaluation. Wearability of sensors. Social impact and patient satisfaction.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
- Model description
- Three phases: in the first, focus groups and living labs are conducted to co-create the solution with patients; in the second, as the first action of the cmRCT, an RCT is conducted to verify the effectiveness of the initial ROOMMATE system; in the third, a pilot is conducted to preliminarily test the advanced version of the ROOMMATE system.
| Arm | Type | Receives |
|---|---|---|
| Conventional rehabilitation (Group A) | Active comparator | Other: Active Comparator: Conventional rehabilitation (Group A)The first 140 patients who meet the inclusion criteria will be randomized between this group and group B. This group will undergo conventional therapy. |
| ROOMMATE 1st (Group B) | Experimental | Device: ROOMMATE 1stThe 70 patients randomized to this group will undergo conventional treatment and, in addition, will have the first version of the ROOMMATE system. |
| ROOMMATE 2nd (Goup B2) | Experimental | Device: ROOMMATE 2ndGroup B2 will undergo conventional treatment and will have an extended version of the bedside multimedia monitor apparatus, integrated with an inertial sensor to enable the serious games on the experimental platform. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- outcome of ischemic or hemorrhagic stroke in subacute phase (< 3 months after the event)
- willingness to participate in the project, with informed consent signed by the subject or, when necessary, by the support administrator.
Key exclusion criteria (5 listed)
- severe visual and/or auditory impairments that cannot be corrected
- severe cognitive and/or speech impairments that interfere with the ability to use the HKK system and the SensoMode accessory independently and/or in the
- absence of a caregiver who can assist the patient in using the system;
- skin lesions that prevent wearing the inertial sensors;
- presence of signs of clinical instability, defined by a score greater than zero on the Clinical Instability Scale (SIC).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Active Comparator: Conventional rehabilitation (Group A)The conventional group will undergo standard rehabilitation treatment according to the rehabilitation plan developed by the rehabilitation team. This group will undergo 3 hours of rehabilitation per day and will carry out face-to-face rehabilitation following an impairment-based approach aimed at the treatment of motor-cognitive functions. | Other | Conventional rehabilitation (Group A) |
| ROOMMATE 1stIn addition to Group A, this group will have the bedside multimedia monitor apparatus to access informative, rehabilitation, and entertainment content. Additionally, this group will have a digital and innovation coach to receive support in using the technology. | Device | ROOMMATE 1st (Group B) |
| ROOMMATE 2ndOnce the first RCT of the cmRCT is completed, a pilot RCT will be initiated, randomizing 60 cases between Group A and this group. In addition to conventional treatment, this group will have a version of the ROOMMATE system integrated with inertial sensors worn on the hands and fingers to guide the serious games on the platform. | Device | ROOMMATE 2nd (Goup B2) |
Primary outcome
modified Barthel index (mBI)
Time frame: baseline, 3 week
Assessment of disability in ADLs, scoring 0-100
12 secondary outcomes
Nine Hole Peg Test
Time frame: baseline, 3 week
Fugl Meyer Assessment (FMA)
Time frame: baseline, 3 week
Functional Ambulation Category (FAC)
Time frame: baseline, 3 week
Montreal Cognitive Assessment (MOCA)
Time frame: baseline, 3 week
Hearts Test
Time frame: baseline, 3 week
Short Form 12 item
Time frame: baseline, 3 week
Training-Evaluation-Inventory (TEI)
Time frame: 3 week
Short Version of the User Experience Questionnaire (UEQ-S)
Time frame: 3 week
Final Measurement Scales for Perceived Usefulness and Perceived Ease of Use
Time frame: 3 week
HUBBI - eHealth UsaBility Benchmarking Instrument
Time frame: 3 week
we wearability test
Time frame: 3 week
Motricity Index
Time frame: baseline, 3 week
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Mar 2025.
- Derived from this study: PubMed 41164394Doronzio S, Jansen-Kosterink S, Tesi M, Castagnoli C, Pedrini C, Ciapetti T, De Marco M, Piazzini M, Giacani J, Ciobanu I, Berteanu M, Fiorini L, Rovini E, Cavallo F, Agnoloni F, Baccini M, Cecchi F. Development of a cohort multiple randomized clinical trial to test an integrated system of sensors and multimedia monitors technology, for stroke rehabilitation: the ROOMMATE study protocol. Front Neurol. 2025 Oct 14;16:1568728. doi: 10.3389/fneur.2025.1568728. eCollection 2025.
- Individual participant dataSharing planned: Yes. After publishing the results in international congresses and conferences and in impacted journals, the project partners, according to the stipulated data management plan will disseminate the results following the principle of "as open as possible, as closed as needed". Resuls will be shared on a Zenodo-like repository.
Related trials for Subacute Stroke
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Functional Improvement in Subacute/Chronic Stroke Through Non-invasive Virtual-reality-Based Telerehabilitation
Stroke
Active, not recruiting
Comparative Effects of Sensorimotor Training and tACS on Upper Limb Function and Cervical Proprioception in Subacute Stroke
Sub-acute Stroke
Not yet recruitingObservational study
Detecting and Predicting Post-stroke Cognitive Impairment Using the Oxford Cognitive Screen
Stroke, Ischemic Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Active Comparator: Conventional rehabilitation (Group A), ROOMMATE 1st and ROOMMATE 2nd in people with Subacute Stroke and Stroke; Subacute, run by Francesca Cecchi at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 21 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Francesca Cecchi (+39 3388627184, fcecchi@dongnocchi.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
modified Barthel index (mBI) (time frame: baseline, 3 week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06728020, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2025.